午间公告：贝达药业盐酸恩沙替尼胶囊获美国FDA批准上市

Group 1 - Company Xcovery, a subsidiary of BeiGene, has received FDA approval for its drug Ensacove (ensartinib) [1] - The approved indication is for the treatment of adult patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not received prior ALK inhibitor therapy [1]